Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Akito Nishida"'
Development of a learning environment for sketching human body with pose change using Motion Capture
Autor:
Masato Soga, Akito Nishida
Publikováno v:
KES
We have been developing learning support systems for sketching human body. A learning support system compares an artwork by learners with a model of the human body figure in regard to a skeleton or an outline and presents the difference between them
Autor:
Motoko Ida1 motoko.ida@astellas.com, Akito Nishida2, Hiraku Akiho3, Yoshihiro Nakashima4, Kei Matsueda5, Shin Fukudo6
Publikováno v:
BioPsychoSocial Medicine. 3/16/2017, Vol. 11, p1-10. 10p.
Autor:
Motoko Ida1 motoko.ida@astellas.com, Akito Nishida2, Hiraku Akiho3, Yoshihiro Nakashima4, Kei Matsueda5, Shin Fukudo6
Publikováno v:
BioPsychoSocial Medicine. 3/11/2017, Vol. 11, p1-12. 12p.
Autor:
Ingrid Gagainis, Akito Nishida, Bernhardt Zeiher, Rob Arbuckle, Leticia Delgado-Herrera, Kathryn Lasch, Benjamin Banderas, Susan Zentner, Ana Popielnicki
Publikováno v:
Patient Related Outcome Measures
Leticia Delgado-Herrera,1 Kathryn Lasch,2 Ana Popielnicki,3 Akito Nishida,4 Rob Arbuckle,5 Benjamin Banderas,6 Susan Zentner,1 Ingrid Gagainis,1 Bernhardt Zeiher1 1Astellas Pharma Global Development, Northbrook, IL, 2Pharmerit International, Newton,
Publikováno v:
Biopsychosocial Medicine
Background Global assessment allows patients to assess improvement in multiple irritable bowel syndrome (IBS) symptoms. However, it was deemed important to assess “clinically meaningful improvements, focusing on the patient’s chief complaint and
Publikováno v:
European Journal of Clinical Pharmacology. 64:691-695
To investigate the effects of multiple doses of fluvoxamine on the pharmacokinetics, safety, and tolerability of a single oral 10-mug dose of ramosetron.This was a single-center, open, one-sequence cross-over study. On Day 1, healthy male and female
Autor:
Hamish Ryder, Masato Satoh, Michael Szelke, Andrzej Roman Batt, Graeme Semple, Akito Nishida, Rooker David Philip, David Alan Kendrick, Shinobu Akuzawa, Mitsuaki Ohta, Keiji Miyata
Publikováno v:
Journal of Medicinal Chemistry. 40:331-341
A number of new 1,4-benzodiazepin-2-one-based gastrin/CCK-B receptor antagonists related to the archetypal analogue L-365,260, and more closely to the recently reported compound YM022, have been synthesized and evaluated for biological activity. The
Autor:
Yukihiro Takemoto, Hiroyuki Ito, Akito Nishida, H Yuki, Yusuke Takinami, Akira Miyake, Keiji Miyata, Shinobu Akuzawa
Publikováno v:
Digestive Diseases and Sciences. 42:707-714
We examined the affinity of YM022, a potent andselective gastrin/CCK-B receptor antagonist, for caninegastrin/CCK-B and CCK-A receptors and the effects ofYM022 on secretagogue- and peptone meal-induced acid secretion in the denervated, surgicallysepa
Autor:
Hamish Ryder, Akito Nishida, Andrzej Roman Batt, Keiji Miyata, Graeme Semple, Elizabeth Mathews, Michael Szelke, David Alan Kendrick, Rooker David Philip
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:2971-2976
The design, synthesis and biological activity of two novel series of compounds derived from the basic Boc-CCK-4 structure which provide potent ligands for the gastrin/CCK-B receptor is outlined. Within these series, new pseudopeptide compounds were d
Autor:
Hamish Ryder, Masato Satoh, Akito Nishida, Michael Szelke, Graeme Semple, David Alan Kendrick, Keiji Miyata, Shinobu Akuzawa, Mitsuaki Ohta
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:51-54
A novel series of 1-alkylcarbonylmethyl analogues of the potent gastrin/CCK-B receptor antagonist YM022 have been prepared. A number of analogues retained good affinity for the gastrin/CCK-B receptor and one compound (6d) showed improved binding and